Announcement reinforces SGS’s position as one of the few European CROs offering end-to-end human ADME programs This ...

The presentation by Dr. Dirk Beher, Chief Executive Officer of FundaMental Pharma, will highlight the scientific foundation for lead candidate FMP374, the distinctive approach to modulating NMDAR, and ...

The lawyers featured in this list represent excellence across diverse practice areas, from corporate law and litigation to intellectual property and regulatory compliance.

Clay brings a distinguished track record in global project delivery and site relationship strategy. He has led large-scale ...

Biotech dealmaking is increasingly defined by a clear strategic shift: Pharmaceutical companies are prioritizing de-risked, late-stage assets with human clinical validation rather than speculative ...

As Bangladesh steps into a new political chapter with the promise of an Upper House adding fresh dimensions to governance, ...

Dry eye disease is a common ocular condition that can significantly impair quality of life, and dysfunction of the meibomian glands is a major contributing factor. Advances in infrared meibography ...

Nuclera, the biotechnology company enabling rapid access to high-quality proteins and leadXpro, a specialist in ...

Have you ever seen a hibiscus flower? Although its petals have a range of colors, what makes the trumpet-shaped flower more ...

Childers focused her doctoral studies on education policy, a specialization that soon intersected with her professional path. A new job gave her the perfect opportunity to apply what she was learning ...

–Remain On Track to Initiate CYC-126's Phase 2 Proof-of-Concept (“POC”) Study in Treatment Resistant Depression (“TRD”) in the Second Half of 2026– ...

Nucleome Therapeutics appoints experienced biotech executive Dr. Michelle Morrow as Chief Scientific Officer Brings deep expertise in immunology, oncology and pharmacology with a strong track record ...